Clinical trials
Root Resorption trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 6 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 6 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Al-Azhar University | 4 |
| Jordan University of Science and Technology | 2 |
| University of Baghdad | 2 |
| Ain Shams University | 1 |
| Aya Ahmed Moursi El Faham | 1 |
| Beni-Suef University | 1 |
| Can Tho University of Medicine and Pharmacy | 1 |
| Damascus University | 1 |
| Dow University of Health Sciences | 1 |
| Faculty of Dental Medicine for Girls | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Root Resorption | 25 |
| Malocclusion | 2 |
| Pain | 2 |
| Agnosia | 1 |
| Dental Plaque | 1 |
| Dental Pulp Necrosis | 1 |
| Gingival Diseases | 1 |
| Gingivitis | 1 |
| Malocclusion, Angle Class I | 1 |
| Overbite | 1 |
Trials
Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.